AACR Annual Meeting 2018: Off-the-shelf CAR T-cell Immunotherapy – Are we There Yet?
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
Tag: immunotherapy
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...
While Cancer Research Catalyst covers the spectrum of cancer research news, we weren’t surprised to discover that the hottest...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics...
This week, some of the world’s leading cancer researchers are gathering in Mainz/Frankfurt, Germany for the Third International Cancer...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
A pair of studies published recently in journals of the American Association for Cancer Research bring to our attention...